Skip Navigation

Phase I/II study of Silmitasertib CX-4945 in combination with chemotherapy in children and young adults with relapsed refractory solid tumors

Brief Summary

Type:
Other

Study Type:
Treatment

Phase:
I/II

ClinicalTrials.gov Identifier:
NCT06541262

Study #:
CMH - BCC021

Start Date:
Mar 19, 2025

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT06541262

View Complete Trial Details & Eligibility at ClinicalTrials.gov